A wireless retinal implant can restore central vision in patients with advanced age-related macular degeneration (AMD), according to clinical trial results published in the New England Journal of Medicine.
The technique sounds so outlandish that it won an IgNobel prize in 2024. But the science behind rescuing people with blocked airways and clogged lungs by rectally delivering oxygen to the body is no joke.
DENTON, Texas, Oct. 20, 2025 /PRNewswire/ — ManaMed today announced FDA 510(k) clearance for PlasmaFlow® X, the next-generation, tubeless sequential compression system that’s redefining recovery. Cleared as a Class II device, PlasmaFlow X is more compact, smarter, and longer-lasting—delivering powerful therapy in a sleek, portable package.
Glaukos (NYSE:GKOS) announced today that the FDA approved its Epoxia incision-free alternative to traditional corneal cross-linking procedures.
Rhythio Medical announced today that it received FDA breakthrough device designation for its Injectable Electrode System.
Enabled by a new high-resolution mapping technique, the findings overturn a long-held belief that the genome loses its 3D structure when cells divide.
In addition to linguistic prompts, large language models can also understand, interpret, and adapt their responses to heart frequency data. Dr. Morris Gellisch, previously of Ruhr University Bochum, Germany, and now at University of Zurich, Switzerland, and Boris Burr from Ruhr University Bochum have developed a technical interface through which the physiological data can be transmitted to the language model in real time.
Researchers from Edith Cowan University (ECU) have developed an innovative new way to measure biological age, which could make it easier to detect and track age-related conditions.
When cancer spreads, tiny amounts of cells can break away from tumors and circulate in the bloodstream. A liquid biopsy is a means to detect the presence of cancer by detecting these cancer cells floating in blood samples. However, current state-of-the-art methods have necessitated trained specialists to comb through and review images of thousands of cells out of potentially millions of cells on a slide over a period of many hours.
The initiative is set to continue until the end of 2025, with backing from Google.org.